Services - Nanomedicine - CD Formulation

Complete Solutions for Nanoformulation Development

Collaborate with CD Formulation on projects covering the entire nanoformulation development process, including pre-formulation studies, formulation development, process scale-up, and manufacturing processes for CGMP production.

Formulation Development

CD Formulation supports a full range of nano preparation formulation development, including but not limited to solid lipid nanoparticles (SLNs), albumin nanoparticles, liposome nanoparticles (LNPs), polymer nanoparticles, liposome, exosome, nanoemulsion, nanocrystals, etc.

Nanoformulation Analysis

CD Formulation is good at nano property characterization through utilizing various techniques including electron microscopy, atomic force microscopy, X-ray diffraction, spectroscopy, and dynamic light scattering.

Nanoformulation Biological Evaluation

CD Formulation stresses the significance of biologically evaluating nanoformulations, providing services such as hemolysis testing, cellular uptake assays, safety assessments, and research on pharmacokinetics and biodistribution.

Analytical Method Development and Validation

CD Formulation has state-of-the-art equipment and extensive experience to support in developing, optimizing, and validating rigorous analytical methods for any ingredient in any nanoformulation.

Batch Release Testing

CD Formulation uses a full set of analytical technologies to provide validated batch release testing for your APIs and nanoformulations, ensuring bring your drug products to market as quickly as possible.

Commercial Manufacturing

CD Formulation is committed to producing nanoformulations that meet your needs in accordance with cGMP standards, helping you achieve your research and commercial goals.

Supporting Analysis Services for Nanoformulation Development

With deep expertise in nanoformulation development, CD Formulation applies advanced analytical methods to support the characterization of drug substances, raw materials, and/or nanoparticle formulations. We continually improve and update our analytical methods and remain current on the latest technology and industry developments to meet our client's changing needs and challenges.

Nanoformulation Characterization

Particle Size Distribution (PDI)
Osmolality
Zeta-Potential
pH
Encapsulation Efficiency
Total Drug Substance Content
In Vitro Potency
...

Nanoformulation Quality Control

Multi-Lipid Content Testing
Raw Material Testing
Forced Degradation
Residual Solvents
Solubility Testing
Trace Impurity Analysis
Storage Stability Testing
...

Instrumentation

Dynamic Light Scattering (DLS)
Cryo-TEM
LC-MS/MS
UHPLC-UV
HPLC-ELSD
UHPLC-CAD
Bioanalyzer
...

Why Choose CD Formulation?

Has comprehensive knowledge, insights, and expertise in formulation development, process development, analytical development, quality, and GMP manufacturing.
Leverage nanotechnology technology platforms to optimize using carrier materials, enabling seamless scaling of drug products from preclinical to clinical development.
Flexible capabilities in nanoformulation development or transfer protocols to continue development in-house.
End-to-end workflow from preformulation studies to commercial cGMP manufacturing.